Insulin and Glucagon Co-administration – Optimizing Glycemic Control without Risks of Hypoglycemia
Aug 29, 2020
Editor: David L. Joffe, BSPharm, CDE, FACA
Author: Melinda Rodriguez, PharmD Candidate 2021, Lake Erie College of Osteopathic Medicine – L|E|C|O|M School of Pharmacy
Opposing actions of insulin and glucagon may be the key to glucose control.
The risk of hypoglycemia is of enormous concern among people with diabetes on insulin-containing regimens. These risks are even higher in those taking beta-blockers, as symptoms of low blood sugar can be masked by the drug. People of older age showing cognitive decline are also at higher risk and may not notice life-threatening drops in glucose levels when they occur. Considerable effort is required by both the patient and provider to manage and coordinate diet, activity, insulin administration, and blood glucose monitoring. Despite advancements in medicine and technology, the risk of hypoglycemia remains a significant obstacle in diabetes management....
Agreement to pay later is required for access to the full text of this article. You will be charged only after your use reaches $5.00 (US) of site content. The costs of producing a newsletter like Diabetes in Control have been increasing, which is why we are asking our readers to help support our ability to continue to bring you quality information about diabetes through charging a minimal price to read certain articles. Thank you for helping to support Diabetes in Control.